Geoffrey F Cox

Title: Innovations of Geoffrey F. Cox in Biotherapeutics

Introduction

Geoffrey F. Cox is a notable inventor based in Boston, MA, recognized for his contributions to the field of biotherapeutics. He has developed innovative methods for producing fusion proteins in transgenic mammal milk, which have significant implications for therapeutic applications.

Latest Patents

Cox holds a patent for a method that allows for the production of desirable fusion proteins in the milk of transgenic animals. This method enables the purification of these proteins, which are made as fusion proteins with partners like human alpha-fetoprotein. The fusion partner not only enhances the half-life of the molecule but also provides therapeutic benefits. The production process leverages transgenic animals, allowing for high yield and biocompatibility, while also enabling specific post-translational modifications in the mammary gland.

Career Highlights

Cox is associated with GTC Biotherapeutics, Inc., where he has been instrumental in advancing biotherapeutic technologies. His work focuses on biologically active polypeptides that combine therapeutic polypeptides with human alpha-fetoprotein fragments. This innovative approach has the potential to revolutionize the production of therapeutic proteins.

Collaborations

Cox collaborates with Harry M. Meade, contributing to the advancement of biotherapeutic research and development.

Conclusion

Geoffrey F. Cox's innovative work in the production of fusion proteins represents a significant advancement in biotherapeutics. His contributions have the potential to enhance the efficacy of therapeutic proteins and improve patient outcomes.